Abstract

Stereotyped behavior is elicited by activation of dopaminergic systems with drugs such as apomorphine and amphetamine. In previous studies, we have reported that the sulfated cholecystokinin octapeptide (CCK-8) decreased apomorphine-induced stereotypy in animals with normal and supersensitive dopamine receptors. The aim of the present study was to evaluate the effects of CCK 1 and CCK 2 receptor antagonists on stereotyped behavior induced by apomorphine or amphetamine. Rats were pretreated with the CCK 1 (SR 27897B; 1-[[2-(4-(2-chlorophenyl) thiazol-2-yl) aminocarbonyl]indolyl]acetic acid; 500 μg/kg; i.p.) or CCK 2 (L-365,260; 3R-(+)- N-(2,3-dihydro-1-methyl-2-oxo-5 phenyl-1 H-1,4-benzodiazepine-3-yl)- N′-(3-methyl phenyl)-urea; 500 μg/kg; i.p.) receptor antagonists or saline 15 min before apomorphine (0.6 mg/kg; s.c.) or amphetamine (9.0 mg/kg; i.p.) injection. Both CCK 1 and CCK 2 receptor antagonists significantly increased apomorphine-induced stereotypy. In contrast, only the blockade of CCK 2 receptors significantly decreased amphetamine-induced stereotypy. The results suggest a dual opposite mechanism for CCK–dopamine interactions. These data also suggest that both apomorphine- and amphetamine-induced stereotypy should be used whenever effects of drugs acting on dopaminergic systems are being assessed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call